245 related articles for article (PubMed ID: 28147343)
1. The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.
Fancello L; Kampen KR; Hofman IJ; Verbeeck J; De Keersmaecker K
Oncotarget; 2017 Feb; 8(9):14462-14478. PubMed ID: 28147343
[TBL] [Abstract][Full Text] [Related]
2. p53-Independent cell cycle and erythroid differentiation defects in murine embryonic stem cells haploinsufficient for Diamond Blackfan anemia-proteins: RPS19 versus RPL5.
Singh SA; Goldberg TA; Henson AL; Husain-Krautter S; Nihrane A; Blanc L; Ellis SR; Lipton JM; Liu JM
PLoS One; 2014; 9(2):e89098. PubMed ID: 24558476
[TBL] [Abstract][Full Text] [Related]
3. Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond-Blackfan anemia.
Cmejla R; Cmejlova J; Handrkova H; Petrak J; Petrtylova K; Mihal V; Stary J; Cerna Z; Jabali Y; Pospisilova D
Hum Mutat; 2009 Mar; 30(3):321-7. PubMed ID: 19191325
[TBL] [Abstract][Full Text] [Related]
4. Ribosomal protein L5 (RPL5)/ E2F transcription factor 1 (E2F1) signaling suppresses breast cancer progression via regulating endoplasmic reticulum stress and autophagy.
Ma X; Li Y; Zhao B
Bioengineered; 2022 Apr; 13(4):8076-8086. PubMed ID: 35293275
[TBL] [Abstract][Full Text] [Related]
5. Loss of tumor suppressor RPL5/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity.
Teng T; Mercer CA; Hexley P; Thomas G; Fumagalli S
Mol Cell Biol; 2013 Dec; 33(23):4660-71. PubMed ID: 24061479
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint.
Oršolić I; Bursać S; Jurada D; Drmić Hofman I; Dembić Z; Bartek J; Mihalek I; Volarević S
Oncogene; 2020 Apr; 39(17):3443-3457. PubMed ID: 32108164
[TBL] [Abstract][Full Text] [Related]
7. Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations.
Quarello P; Garelli E; Carando A; Brusco A; Calabrese R; Dufour C; Longoni D; Misuraca A; Vinti L; Aspesi A; Biondini L; Loreni F; Dianzani I; Ramenghi U
Haematologica; 2010 Feb; 95(2):206-13. PubMed ID: 19773262
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal protein RPL5 regulates colon cancer cell proliferation and migration through MAPK/ERK signaling pathway.
Zhang H; Liu J; Dang Q; Wang X; Chen J; Lin X; Yang N; Du J; Shi H; Liu Y; Han J
BMC Mol Cell Biol; 2022 Nov; 23(1):48. PubMed ID: 36384455
[TBL] [Abstract][Full Text] [Related]
9. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
10. WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5-MDM2-p53 pathway.
Li Y; Zhou Y; Li B; Chen F; Shen W; Lu Y; Zhong C; Zhang C; Xie H; Katanaev VL; Jia L
Oncogene; 2020 Mar; 39(13):2741-2755. PubMed ID: 32005977
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
12. MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.
Tong D; Zhang J; Wang X; Li Q; Liu LY; Yang J; Guo B; Ni L; Zhao L; Huang C
Oncogenesis; 2020 Jun; 9(5):56. PubMed ID: 32483207
[TBL] [Abstract][Full Text] [Related]
13. Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.
Kamio T; Gu BW; Olson TS; Zhang Y; Mason PJ; Bessler M
PLoS One; 2016; 11(4):e0152263. PubMed ID: 27042854
[TBL] [Abstract][Full Text] [Related]
14. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
Ring A; Kaur P; Lang JE
BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
[TBL] [Abstract][Full Text] [Related]
15. Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Schwarzenbacher D; Stiegelbauer V; Deutsch A; Ress AL; Aigelsreiter A; Schauer S; Wagner K; Langsenlehner T; Resel M; Gerger A; Ling H; Ivan C; Calin GA; Hoefler G; Rinner B; Pichler M
Oncotarget; 2015 May; 6(13):11191-202. PubMed ID: 25857299
[TBL] [Abstract][Full Text] [Related]
16. Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.
Meng D; Yu Q; Feng L; Luo M; Shao S; Huang S; Wang G; Jing X; Tong Z; Zhao X; Liu R
Clin Transl Oncol; 2019 Jul; 21(7):910-923. PubMed ID: 30565087
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibitory effects of large subunit ribosomal proteins in melanoma.
Kardos GR; Dai MS; Robertson GP
Pigment Cell Melanoma Res; 2014 Sep; 27(5):801-12. PubMed ID: 24807543
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop.
He X; Li Y; Dai MS; Sun XX
Oncotarget; 2016 Mar; 7(13):16217-26. PubMed ID: 26908445
[TBL] [Abstract][Full Text] [Related]
19. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
[TBL] [Abstract][Full Text] [Related]
20. Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex.
Liao JM; Zhou X; Gatignol A; Lu H
Oncogene; 2014 Oct; 33(41):4916-23. PubMed ID: 24141778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
